Which has the lower trailing P/E, ABBV or CI?

CI has the lower trailing P/E: ABBV trades at 72.43 and CI at 11.62. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or CI?

Over the past five years, CI grew revenue faster — ABBV at a 3.69% CAGR versus CI at 11.11%.

Does ABBV or CI pay a bigger dividend?

ABBV yields 2.68% and CI yields 2.20% based on trailing dividends and the latest price.

Is ABBV or CI more profitable?

ABBV runs the higher net margin — ABBV at 9.81% versus CI at 2.27%.

How have ABBV and CI total returns compared?

Over the past 10 years, ABBV delivered 19.76% and CI delivered 9.30% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Cigna Corporation (CI)

A side-by-side comparison of AbbVie Inc. and Cigna Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$454.17B

$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Cigna Corporation

$74.19B

$280.76HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — ABBV vs CI

growth of $100 · dividends reinvested · last 10y

ABBV +507.0% (+19.8%/yr)CI +144.8% (+9.4%/yr)ABBV compounded faster over this window

ABBV CI

ABBV vs CI: by the numbers

•ABBV is the larger company ($454.17B vs $74.19B market cap).
•CI trades at the lower trailing earnings multiple (11.62 vs 72.43 P/E), one valuation lens rather than an overall verdict.
•ABBV converts more revenue to profit (9.81% vs 2.27% net margin).
•CI grew revenue faster over the past five years (11.11% vs 3.69% CAGR).
•ABBV pays the higher dividend yield (2.68% vs 2.20%).

Metrics side by side

Valuation

Metric	ABBV	CI
P/E ratio	72.43	11.62
Forward P/E	18.32	9.20
P/S ratio	7.05	0.26
P/B ratio	N/A	1.74
EV / EBITDA	19.34	8.08
FCF yield	3.99%	12.28%

Profitability

Metric	ABBV	CI
Gross margin	71.48%	11.66%
Operating margin	29.32%	3.46%
Net margin	9.81%	2.27%
ROE	N/A	15.05%
ROIC	13.46%	7.69%

Dividends

Metric	ABBV	CI
Dividend yield	2.68%	2.20%
Payout ratio	192.43%	25.62%

Growth (annualized)

Metric	ABBV	CI
Revenue CAGR (5Y)	3.69%	11.11%
EPS CAGR (5Y)	-2.79%	-0.76%
FCF CAGR (5Y)	0.11%	-1.95%
Total return CAGR (5Y)	23.51%	8.53%

Frequently asked

Which has the lower trailing P/E, ABBV or CI?: CI has the lower trailing P/E: ABBV trades at 72.43 and CI at 11.62. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or CI?: Over the past five years, CI grew revenue faster — ABBV at a 3.69% CAGR versus CI at 11.11%.
Does ABBV or CI pay a bigger dividend?: ABBV yields 2.68% and CI yields 2.20% based on trailing dividends and the latest price.
Is ABBV or CI more profitable?: ABBV runs the higher net margin — ABBV at 9.81% versus CI at 2.27%.
How have ABBV and CI total returns compared?: Over the past 10 years, ABBV delivered 19.76% and CI delivered 9.30% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full CI analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Cigna P/E ratio AbbVie dividend yield Cigna dividend yield AbbVie ROE Cigna ROE AbbVie operating margin Cigna operating margin AbbVie revenue growth Cigna revenue growth AbbVie free cash flow Cigna free cash flow

AbbVie & Cigna appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.